Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Induction with Sevoflurane

PreclinicalSmall molecule

UUniversity Hospital, Bordeaux

Induction with Sevoflurane is one of 2 small molecule programs targeting Sevoflurane. It is currently in Preclinical.

1

Indications

1

Total Trials

0

Active Trials

1

Competitors

Pipeline

Status by Indication[3][1]

Indication

SevofluraneCompleted

SevofluranePreclinical

Completed

Competition

Competitive Landscape

4 competitors in Sevoflurane

#DrugCompanyPhaseTrials

Aquachloral

SSeoul National University Hospital

Induction with Sevoflurane

UUniversity Hospital, Bordeaux

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Sevoflurane1 trial

Interest of the Induction With Target-controlled Inhalation of Sevoflurane on Spikes Wave Occurrence

Completed·UUniversity Hospital, Bordeaux·N/A·NCT00775879·34 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Induction with Sevoflurane. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Induction with Sevoflurane compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Induction with Sevoflurane. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University Hospital, Bordeaux company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: UUniversity Hospital, Bordeaux

Related News